ゲンタマイシン耳毒性における蝸牛有毛細胞障害に対するスフィンゴシン1リン酸受容体アンタゴニストの効果 by 中山 雅博
The influence of sphingosine-1-phosphate
receptor antagonists on gentamicin-induced
hair cell loss of the rat cochlea
著者 中山 雅博
year 2014
その他のタイトル ゲンタマイシン耳毒性における蝸牛有毛細胞障害に
対するスフィンゴシン1リン酸受容体アンタゴニス
トの効果
学位授与大学 筑波大学 (University of Tsukuba)
学位授与年度 2014
報告番号 12102乙第2705号
URL http://hdl.handle.net/2241/00142055

The influence of sphingosine-1-phosphate receptor 
antagonists on gentamicin-induced hair cell loss of 
the rat cochlea. 
（ゲンタマイシン耳毒性における蝸牛有毛細胞障害に対す
るスフィンゴシン 1リン酸受容体アンタゴニストの効果） 
2014 
筑波大学大学院博士課程人間総合科学研究科
中山 雅博
CONTENTS 
1. INTRODUCTION・・・・・・・・・・・・・・・・・・・・・・・3
2. MATERIALS AND METHODS・・・・・・・・・・・・・・・・・5
2-1. Animals 
2.2. Reverse transcription-polymerase chain reaction (RT-PCR) 
2.3. Culture technique 
2.4. S1P receptor antagonists 
2.5. Cytochemistry 
2.6. Assessment of cochlear hair cell damage 
2.7. Western blot analysis 
2.8. Data analysis 
3. RESULTS・・・・・・・・・・・・・・・・・・・・・・・・・・11
3.1 Expression of S1PRs in the cochlea 
3.2 Effects of S1PR antagonists on cochlear hair cells (control study) 
3.3 Effects of S1PR antagonists on gentamicin ototoxicity 
3.4. Activation of the intrinsic apoptotic pathway in gentamicin 
ototoxicity 
4. DISCCUSION・・・・・・・・・・・・・・・・・・・・・・・・14
1 
5. CONCLUSIONS ・・・・・・・・・・・・・・・・・・・・・・・16
6. ACKNOWLEDGMENTS・・・・・・・・・・・・・・・・・・・・17
7. REFERENCES・・・・・・・・・・・・・・・・・・・・・・・・18
8. FIGURES ・・・・・・・・・・・・・・・・・・・・・・・・・・22
9. FIGURES LEGENDS・・・・・・・・・・・・・・・・・・・・・26
2 
1. Introduction
Sphingolipid metabolites, such as ceramides and sphingoid bases, have 
been implicated in the modulation of membrane signal transduction systems 
and in diverse cellular processes, such as cell proliferation, survival, 
migration, and angiogenesis [1,2,3,4]. We recently reported that exogenously 
applied sphingosine-1-phosphate (S1P) protected cochlear hair cells against 
gentamicin ototoxicity [5]. S1P exerts its cellular responses through a family 
of 5 G-protein-coupled S1P receptors (S1PRs) known as S1PR1-5 [6,7,8,9]. 
These S1PRs are differentially expressed in various cell types. S1PR1, S1PR2, 
and S1PR3 are widely expressed in cells and tissues, whereas S1PR4 and 
S1PR5 are expressed only in the cells of the immune and nervous systems 
[10]. Presence of S1PR1-3 has been shown in the organ of Corti [11,12], but 
expression of S1PR4,5 has never been examined before. 
Aminoglycoside antibiotics are widely used for the treatment of 
infectious diseases. However, the clinical usage of aminoglycosides has often 
been limited owing to their side effects-ototoxicity and nepherotoxicity. 
Aminoglycosides are well known to damage cochlear inner ear hair cells, 
causing sensorineural hearing loss and balance disturbance [12]. Recent 
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findings have demonstrated that death of cochlear hair cells was elicited by 
gentamicin via an apoptotic pathway, at least in part [13,14]. Particularly, 
evidence of the involvement of the intrinsic apoptotic pathway in gentamicin 
ototoxicity has been demonstrated [15].  
The present study was designed to investigate the expression of S1PRs
 
in the rat cochlea and to examine the role of S1PRs in hair cell death induced 
by gentamicin.  
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2. Materials and methods 
2.1. Animals 
Postnatal days 3 (P3) to 5 (P5) Sprague-Dawley rats were used. All 
animal procedures were carried out according to the guidelines of the 
Laboratory Animal Research Center of Tsukuba University. 
2.2. Reverse transcription-polymerase chain reaction (RT-PCR) 
The cochlea, organ of Corti, and spiral ganglion were dissected. Total 
RNA was extracted from each cell, using Trizol (Invitrogen, Carlsbad, CA, 
USA). Reverse transcription was performed using total RNA (1μg) with a 
GeneAmp PCR System 9600 (Perkin Elmer, Tokyo, Japan). The mRNA 
expression levels of S1PR1-5 were detected by conventional RT-PCR with Taq 
polymerase (Takara, Shiga, Japan). 
Glyceraldehyde-3-phoshate dehydrogenase (GAPDH) was used as an 
internal control for RNA integrity. S1PR primer sequences were as follows: 
(1) S1PR1-F: 5’-AGCGTTTGTCTGGAGAAGTACC-3’  
S1PR1-R: 5’-TAGCAAGGAGGCTGAAGACTGA -3’ 
(2) S1PR2-F: 5’-CCTGAGAAGGTTCAGGAACACTAC-3’ 
 S1PR2-R: 5’-CCCAATGAGCATCAACATTCGAC-3’   
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(3) S1PR3-F:5’-ATGTCCGGTAGGAAGACGTTCA-3’ 
 S1PR3-R: 5’-AAGAAAGCACGCCGCATCTC-3’ 
(4)  S1PR4-F:5’-GATCTTGGTGGCTTTTGTGG-3’ 
 S1PR4-R: 5-’CTCTCGCATCTTGAAGCTGA-3’ 
(5)  S1PR5-F:5’-CCAGTGCACAAATGCCAA-3’  
S1PR5-R: 5’-GTTGTAGTGAAGGACGATGAC-3’  
(6) GAPDH-F:5’-AAGGTCATCCCAGAGCTGAA-3’ 
GAPDH-R: 5’-GTTGAAGTCACAGGAGACAACC-3’ 
 
2.3. Culture technique 
The basal turn of the organ of Corti was dissected and cultured 
according to the methods of Van de Water and Ruben [16] and Sobkowicz et 
al. [17]. Cochlear explants were maintained in Dulbecco’s modified Eeagle’s 
medium (DMEM) with 10% fetal bovine serum (FBS), 25mM HEPES, and 
30U/mL penicillin. They were cultured in an incubator at 37°C with 5% CO2 
at 95% humidity. Cochlear cultures were maintained in the above-described 
medium overnight (8-12 hours) and then exposed to a medium containing 
35μM gentamicin for 48 hours to assess the effects of S1PR antagonists 
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[18,19]. Each S1PR antagonist was tested at concentrations of 1 to100 μM. 
 
2.4. S1P receptor antagonists 
S1P and (R)-3-amino-(3-hexylphenylamino)-4- (oxobutylphosp- 
honic) acid (W146, a selective S1PR1 antagonist) and 1-[1,3-Dimethyl- 
1-4-(2-methyllethyl)-1H-pyrazolo[3,4b]pyridin-6-yl]-4-(3,5-dichloro-4-pyridin
yl)-semicar-bazide (JTE013, a selective S1PR2 antagonist) were purchased 
from Sigma Japan (Tokyo, Japan). 2-undecyl-thiazolidine-4-carboxylic acid 
(BML241, a selective S1PR3 antagonist) was purchased from Cayman 
Chemical (Ann Arbor, MI, U.S.A.). W146 was initially dissolved in methanol 
to 10 mM and stored at -20 °C. JTE013 was initially dissolved in dimethyl 
sulfoxide (DMSO) to 10 mM and stored at -20°C. BML241 was initially 
dissolved in dimethylformamide (DMF) to 10 mM and stored at -20°C. Each 
antagonist was diluted in the culture medium to the final concentration 
immediately before use. 
 
2.5. Cytochemistry  
At the end of the tissue culture, the explants were fixed with 4% 
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paraformaldehyde in phosphate-buffered saline (PBS) for 20 minutes and 
then permeabilized with 5% Triton X-100 (Sigma, St Louis, MO) in PBS with 
10% fetal bovine serum (FBS) for 10 minutes. The specimens were stained 
with phalloidin with a conjugated Alexa Fluor probe (1:100, Molecular 
Probes, Carlsbad, CA) at room temperature for 1 hour. Phalloidin is a specific 
marker for cellular F-actin and labels stereociliary arrays and the cuticular 
plates of hair cells [12,18]. All experiments consisted of 8 to 20 explants per 
experimental group. 
 
2.6. Assessment of cochlear hair cell damage  
Hair cells were characterized as missing if no stereocilia or cuticular 
plates were observed by phalloidin staining. Quantitative results were 
obtained by evaluating 30 outer hair cells in a given microscopic field [15]. 
The average of 3 separate counts was used to represent each culture. 
 
2.7. Western blot analysis  
The organ of Corti and the spiral ganglion were homogenized in lysis 
buffer containing 0.25 M sucrose, 50 mM dithiothreitol, 3 mM HEPES (pH 
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7.9), 0.5 mM EGTA, 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 0.8 
mM aprotinin, 21μM leupeptin, 36 μM bestatin, 15μM pepstatin A, 14μM 
(4-guanidino) butane, and 1% Triton X-100. After centrifugation (x12000, 10 
minutes, 4°C), the supernatants were used for Western immunoblot analysis. 
Appropriate volumes of the samples (10μg/lane), were mixed with equal 
volumes of sample buffer (100 mM Tris-HCL, PH 6.8, 4% SDS, 20% glycerol, 
10% 2-mercaptoethanol, and 0.02% bromophenol blue), heated at 95°C for 5 
minutes, and then subjected to SDS-PAGE using 10% polyacrylamide gels. 
The proteins were transferred by semidry electroblotting from the gels to 
polyvinylidene difluoride membranes for 120 minutes. The blots were then 
blocked with the primary antibodies, cleaved caspase 9 or caspase 3 
polyclonal antibody (Cell Signaling Technology, Denvers, MA, USA) for 18 
hours at 4°C. Next, the blots were incubated with an appropriate second 
antibody, horseradish peroxidase-conjugated goat anti-rabbit IgG (Cell 
Signaling Technology), for 1 hour. Immunoreactive bands were visualized 
using enhanced chemiluminescence(ECL kit; GE Healthcare Japan, Tokyo, 
Japan). The scanned immunoblot images were densitometrically analyzed 
with an ImageQuant LAS4000 mini imager (GE Healthcare Japan, Tokyo, 
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Japan). The result of each ratio of examined protein /β‐actin protein was 
obtained from independent measurements (n=6 per group for each 
measurement).  
 
2.8. Data analysis 
All data were expressed as the means±SEMs. Statistical analysis was 
performed by unpaired t‐tests or 1 way analysis of variance (ANOVA) 
followed by Bonferroni post-hoc tests, as required (StatView 5.0). Probability 
values less than 0.05 were considered significant.  
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3. Results  
 
3.1 Expression of S1PRs in the cochlea 
Nonquantitative RT-PCR analysis clearly detected S1PR2 mRNA in the 
organ of Corti and spiral ganglion. S1PR1 and S1PR3 mRNA was also 
detected in both the organ of Corti and the spiral ganglion. In contrast to the 
results for S1PR1-3, no expression of S1PR4 or S1PR5 mRNA was observed 
both in either the organ of Corti or the spiral ganglion (Fig.1).   
 
3.2 Effects of S1PR antagonists on cochlear hair cells (control study) 
In control explants maintained in the initial medium for 48 hours 
without exposure to gentamicin, almost all hair cells including 1 row of inner 
hair cells and 3 rows of outer hair cells were present (Fig.2A). The effects of 
each antagonist and each solvent (W146, DMSO; JTE013, Methanol; 
BML241,DMF) on the outer hair cells were examined and compared with the 
control explants. These antagonists and their solvents did not induce any 
significant outer hair cell loss when explants were cultured for 48 hours in 
the medium containing these agents (data not shown).  
 
3.3 Effects of S1PR antagonists on gentamicin ototoxicity 
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The effect of each antagonist on gentamicin-induced cochlear hair cell 
loss was examined using basal turn explants. The explants treated with 
gentamicin alone showed significantly reduced numbers of outer hair cells 
(Fig. 2A). Compared to the explants treated with gentamicin alone (the 
gentamicin control group), JTE013 increased the ratio of outer hair cell loss 
induced by gentamicin at the concentrations of 10 and 100 μM (Fig. 2A and 
B) (Bonferroni test: p < 0.05). The ratio of outer hair cell loss differed 
significantly between the 10 and 100μM subgroups, suggesting the dose  
-dependency of outer hair cell damage within this range of concentrations 
(Bonferroni test: p < 0.05). However, W146 (1, 10,100μM) or BML241 (1, 
10,100μM) did not influence gentamicin ototoxicity (Fig.2A and B). 
 
3.4. Activation of the intrinsic apoptotic pathway in gentamicin ototoxicity 
The protein expression levels of cleaved caspase-3 and cleaved caspase-9 
in the cochlea were examined by Western blot analysis (Figs. 3 and 4). 
Neither cleaved caspase 3 nor cleaved caspase 9 was detected in the normal 
organ of Corti cultures (without gentamicin). Gentamicin induced expression 
of cleaved caspases 3 and 9. In addition, JTE013 treatment significantly 
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increased expression levels of cleaved caspases 3 and 9 as compared with the 
gentamicin-alone group.  
 
  
13 
 
4. Discussion 
Expression of S1PR1-3 in the organ of Corti was shown in previous 
studies [10,11]. In the present study, we demonstrated that S1PR1-3 mRNA 
was expressed in the spiral ganglion as well as in the organ of Corti of 
Sprague-Dawley rats’. However, S1PR4 and S1PR5 mRNA was not detected 
in the cochlea. The present findings seem reasonable because S1PR1-3 are 
widely expressed in various tissues, whereas  expression of S1PR4  is 
reportedly limited to the lymphoid and hematopoietic tissues and that of 
S1PR5 to the central nervous system [10,20].  
On the basis of the results obtained for S1PR expression in the cochlea, 
we examined the effects of S1PR1-3 antagonists on gentamicin ototoxicity. 
The results showed that the ratio of outer hair cell loss increased in the 
JTE013-treated group as compared with in the gentamicin-alone group. On 
the other hand, W146 or BML241 treatment had no effect on the 
gentamicin-induced damage of hair cells. S1P, produced intracellularly, 
generally functions as an anti-apoptotic substance. In our previous study, 
S1P protected hair cells against gentamicin ototoxicity [5]. The present 
findings strongly suggest that S1PR2 signaling is important for cochlear hair 
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cell survival in gentamicin ototoxicity. Kono et al. [10] and MacLennan et al. 
[21] recently reported that S1P signaling was essential for the maintenance 
of the cochlea in infantile animals via the activation S1PR2. The S1PR2 -null 
mice were profoundly deaf, and the structure of the cochlea in S1PR2 null 
mice was abnormal [10,21]. Their findings support our assumption that 
S1PR2 signaling influences the fate of cochlear hair cells during gentamicin 
exposure. 
The mechanisms of aminoglycoside-induced cochlear hair cell death are 
not fully known. However, it has been reported that the intrinsic apoptotic 
pathway is one of the major pathways leading to cochlear hair cell death 
[15,22]. We examined the activation of the intrinsic apoptotic pathway by 
measuring cleaved caspases 3 and 9. In agreement with the previous reports 
[15,22], gentamicin activated the intrinsic apoptotic pathway. Namely, both 
cleaved caspases 3 and cleaved caspases 9 were detected after gentamicin 
exposure. Furthermore, JTE013, an S1PR2 antagonist, enhanced the 
cleavage of caspases 3 and 9 induced by gentamicin. On the basis of the 
present finding, it is assumed that S1P may inhibit the intrinsic apoptotic 
pathway via S1PR2 in gentamicin ototoxicity. 
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5. Conclusions  
An S1PR2 antagonist enhanced the intrinsic apoptotic pathway of 
cochlear outer hair cells in gentamicin ototoxicity. This finding suggests the 
importance of S1PR2 signaling in cochlear hair cell survival against ototoxic 
insults.  
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Figure Legends  
Figure 1. Expression of S1PRs in the cochlea. RT-PCR analysis demonstrated 
that 3 S1P receptors (S1P1-3) were expressed in the organ of Corti (OC) and 
spiral ganglion (SG) of Sprague-Dawley rats on postnatal days 3 (p3) to 5 
(p5). However, the other 2 S1P receptors (S1P4,5) were not detected. GAPDH 
primers served as a cDNA loading control. (NC; negative control) 
 
Figure 2. Effects of S1P1-3 antagonists on cochlear hair cells. The organ of 
Corti explant was cultured with or without gentamicin. (A) Representative 
microphotographs. (B) The effects of S1P antagonists on gentamicin 
ototoxicity were examined. The organ of Corti was cultured with 35 μM 
gentamicin alone or with 35μM gentamicin plus 100 μM of each S1PR 
antagonist for 48 hours. JTE013 (an S1PR2 antagonist) increased hair cell 
loss at 10 and 100μM as compared with the culture with gentamicin alone 
(p<0.05, 1-way ANOVA and Bonferroni test). Scale bar: 50μm.   
     
Figure 3. Expression levels of cleaved caspase 3 in the organ of Corti were 
assessed by Western blot analysis (n=6 in each group). (A) Typical blot 
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images. β-actin was used as an internal control. Cleaved caspase 3 was not 
detected in the control organ of Corti (without gentamicin). Cleaved caspase 
3 was detected in the explant exposed to gentamicin. JTE013 increased 
expression levels of cleaved caspase 3. (B) Quantitative analysis of cleaved 
caspase-3. Control: tissue sample from organ of Corti maintained in the 
initial medium for 48 h. GM: organ of Corti treated with gentamicin 35 μM 
for 48 h. GM+JTE013: organ of Corti treated with 35 μM gentamicin plus 
100 μM JTE013 for 48 h. 
 
Figure 4. Expression levels of cleaved caspase 9 were assessed by Western 
blotting. (A) Typical blot images. β-actin was used as an internal control. 
Cleaved caspase 9 was not detected in the cotrol organ of Corti (without 
gentamicin). Gentamicin induced cleaved caspase 9, and JTE further 
increased expression level of cleaved caspase 9. 
(B) Quantitative analysis of cleaved caspase-9. control; tissue sample from 
the organ of Corti maintained in the initial medium for 48h. GM; the organ 
of Corti treated with 35μM gentamicin for 48h. GM+JTE013; the organ of 
Corti treated with 35 μM gentamicin plus 100 μM JTE013 for 48 hours. 
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